LONDON, Oct. 14, 2015 /PRNewswire/ -- Coronary arterial disease is one of the leading causes of death in Europe. Interventional cardiology is a minimally invasive technique that uses catheters to treat coronary arterial disease. The most common interventional cardiology procedure is percutaneous transluminal coronary angioplasty (PTCA), which is performed for the management of coronary atherosclerosis. There many different types of complementary devices used during interventional cardiology procedures. These devices include:
- coronary stents,
- PTCA balloon catheters,
- interventional coronary catheters and guidewires,
- coronary embolic protection devices,
- coronary atherectomy devices,
- coronary introducer sheaths,
- coronary vascular closure devices,
- diagnostic coronary catheters and guidewires,
- fractional flow reserve (FFR) guidewires,
- intravascular ultrasound (IVUS) catheters,
- and optical coherence tomography (OCT) catheters.
Cardiovascular disease (CVD) is a common illness, afflicting one in every three individuals in Europe. The effects of CVD can vary from simple high-blood pressure to a fatal stroke. Interventional cardiology is primarily applied to the treatment of coronary heart disease (CHD), which is a specific cardiovascular illness. CHD encompasses myocardial infarction (MI) and angina pectoris, diseases that account for over half of all CVD cases.
The interventional cardiology market includes coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, interventional catheters and guidewires, diagnostic catheters and guidewires, coronary introducer sheaths, embolic protection devices, atherectomy devices, drug-eluting stents and balloons, chronic total occlusion (CTO) devices, vascular closure devices (VCDs), intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.
Advancements in specific technologies and practices such as drug management, drug-eluting stents, drug-eluting balloons, specialty guidewires, bioabsorbable stents, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices. Many of the established standard products have essentially become commodities and are close to homogeneous in their substitutability. Thus, the responsibility is placed upon new or specialized devices that receive positive clinical trials to act as catalysts for growth and to increase the market share of companies that are able to capitalize on such opportunities. For established items such as catheters, guidewires and introducers, companies will have the opportunity to utilize distribution networks and the bundling of multiple products in order to increase revenues as seen with the larger European markets.
Download the full report: https://www.reportbuyer.com/product/3039747/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48